Publications by authors named "Zhenyuan Zheng"

Effectively interfering with endoplasmic reticulum (ER) function in tumor cells and simultaneously activating an anti-tumor immune microenvironment to attack the tumor cells are promising strategies for cancer treatment. However, precise ER-stress induction is still a huge challenge. In this study, we synthesized a near-infrared (NIR) probe, NIR-715, which induces tumor cell death and inhibits tumor growth without causing apparent side effects.

View Article and Find Full Text PDF

Lysyl oxidase-like 2 (LOXL2) is a member of the lysyl oxidase family and has the ability to catalyze the cross-linking of extracellular matrix collagen and elastin. High expression of LOXL2 is related to tumor cell proliferation, invasion, and metastasis. LOXL2 contains 14 exons.

View Article and Find Full Text PDF

In order to improve the high temperature performance of Vegetable oil recycled asphalt, this study used Polyolefin elastomer (POE) and vegetable oil (VO) to compound recycled aging asphalt. The properties of recycled asphalt were compared and analyzed by conventional physical properties and high & low temperature rheological tests. The results show that 8% VO content can achieve the best regeneration effect.

View Article and Find Full Text PDF

Proteins containing a CAAX motif at the C-terminus undergo prenylation for localization and activity and include a series of key regulatory proteins, such as RAS superfamily members, heterotrimeric G proteins, nuclear lamina protein, and several protein kinases and phosphatases. However, studies of prenylated proteins in esophageal cancer are limited. Here, through research on large-scale proteomic data of esophageal cancer in our laboratory, we found that paralemmin-2 (PALM2), a potential prenylated protein, was upregulated and associated with poor prognosis in patients.

View Article and Find Full Text PDF

Purpose: The overall survival of patients with esophageal squamous cell carcinoma (ESCC) is not high due to the lack of markers to evaluate concurrent chemoradiation therapy (CCRT) resistance. The aim of this study is to use proteomics to identify a protein related to radiation therapy resistance and explore its molecular mechanisms.

Methods And Materials: Proteomic data for pretreatment biopsy tissues from 18 patients with ESCC who underwent CCRT (complete response [CR] group, n = 8; incomplete response [ View Article and Find Full Text PDF

Esophageal cancer is the seventh most common cancer in the world. Although traditional treatment methods such as radiotherapy and chemotherapy have good effects, their side effects and drug resistance remain problematic. The repositioning of drug function provides new ideas for the research and development of anticancer drugs.

View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is one of the world's leading causes of death, and its primary clinical therapy relies on surgical resection, chemotherapy, radiotherapy, and chemoradiotherapy. Although the genomic features and clinical significance of ESCC have been identified, the outcomes of targeted therapies are still unsatisfactory. Here, we demonstrate that mitogen-activated protein kinase (MAPK) signaling is highly activated and associated with poor prognosis in patients with ESCC.

View Article and Find Full Text PDF
Article Synopsis
  • Esophageal cancer ranks as the seventh most common cancer worldwide and poses significant challenges due to chemotherapy resistance, particularly with cisplatin.
  • Researchers are investigating how pyroptosis, a specific form of cell death induced by cisplatin, operates on a molecular level to enhance treatment response.
  • Their findings suggest that high levels of calpain-1 and calpain-2 proteins in tumor biopsies correlate with better patient outcomes, indicating their potential as biomarkers for predicting sensitivity to cisplatin-based chemotherapy.
View Article and Find Full Text PDF
Article Synopsis
  • The study found that a protein called STAT3β helps make esophageal cancer cells more sensitive to a drug called cisplatin, which means the drug works better.
  • When STAT3β is present, it messes with the cell's energy process, leading to more harmful substances that trigger cell death.
  • Higher levels of STAT3β and another protein, GSDME, in cancer patients were linked to better chances of surviving and staying healthy after treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying a treatment called CCRT, which combines chemotherapy and radiation for patients with advanced esophageal cancer.
  • They found that a protein called STAT3β helps predict how well patients will respond to this treatment and can indicate a better chance of survival.
  • The researchers discovered that higher levels of STAT3β help cancer cells become more sensitive to the CCRT treatment, making it a potential new factor to consider for patient therapy.
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionn1a8kc30f26bkntdcbkpb046m2af9gs4): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once